What is the role of deferoxamine in the treatment of myelodysplastic syndrome (MDS)?

Updated: Jul 24, 2018
  • Author: Emmanuel C Besa, MD; Chief Editor: Koyamangalath Krishnan, MD, FRCP, FACP  more...
  • Print

Deferoxamine (Desferal) is difficult to administer in elderly patients because it has to be given subcutaneously by pump over 12 hours daily to be effective. It is often given at the same time as the RBC transfusion, although in fact that is ineffective.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!